
AstraZeneca: Cancer Drug Challenges
The Tech Times website reports that the biopharmaceutical company AstraZeneca has announced its decision to release the preclinical data from more than 50 of its medicines as part of the open innovation non-profit biology project called DREAM Challenges, which aims to find drug combinations that can potentially treat cancer. AstraZeneca’s decision
Comments Off on AstraZeneca: Cancer Drug Challenges • Read this story »